| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.174 | 23.888 | 143 | 0 | 35.620 | - | - | - | - | - |
| Total Income - EUR | 1.174 | 23.888 | 143 | 0 | 35.620 | - | - | - | - | - |
| Total Expenses - EUR | 6.399 | 18.216 | 901 | 1.463 | 51.555 | - | - | - | - | - |
| Gross Profit/Loss - EUR | -5.225 | 5.672 | -759 | -1.463 | -15.935 | - | - | - | - | - |
| Net Profit/Loss - EUR | -5.260 | 5.195 | -763 | -1.463 | -16.312 | - | - | - | - | - |
| Employees | 1 | 1 | 0 | 0 | 1 | - | - | - | - | - |
Check the financial reports for the company - Global Inter Pharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.122 | 4.310 | 3.490 | 2.700 | 1.937 | - | - | - | - | - |
| Current Assets | 45.028 | 55.132 | 47.062 | 45.304 | 82.061 | - | - | - | - | - |
| Inventories | 768 | 2.819 | 3.724 | 2.973 | 32.445 | - | - | - | - | - |
| Receivables | 44.228 | 43.847 | 43.105 | 42.279 | 44.344 | - | - | - | - | - |
| Cash | 32 | 8.466 | 233 | 53 | 5.271 | - | - | - | - | - |
| Shareholders Funds | 26.439 | 31.364 | 30.071 | 28.056 | 11.200 | - | - | - | - | - |
| Social Capital | 56 | 56 | 55 | 54 | 53 | - | - | - | - | - |
| Debts | 23.711 | 28.078 | 20.481 | 19.948 | 72.797 | - | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Global Inter Pharm Srl